Eli Lilly & Co. (LLY)
Publicly reported company facts and saved market data for Eli Lilly & Co. (LLY), with sources and as-of times. Saved data is not a live quote.
Company profile
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.3T · as of
- Incorporated in
- United States
- Company website
- www.lilly.com
- Exchange
- NYSE
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $1,414.51
- Reported change
- +2.97%
- Reported volume
- 5,252,086
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float F01 | 849,668,887 | Reported by a single source; not cross-checked. | |
| Historical float F02 | 1,001,099,133 | Historical estimate from the SEC-disclosed public float value; not current tradable shares. | |
| Shares outstanding (O/S) | 941,357,065 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1,268.55 | 1,299.43 | 1,260.34 | 1,288.30 | 2,061,427 | |
| 1,273.50 | 1,297.92 | 1,272.07 | 1,281.91 | 1,849,712 | |
| 1,286.39 | 1,296.90 | 1,273.73 | 1,279.14 | 2,106,876 | |
| 1,304.15 | 1,307.92 | 1,257.62 | 1,273.46 | 2,277,425 | |
| 1,281.76 | 1,321.21 | 1,275.10 | 1,306.69 | 2,660,304 | |
| 1,266.90 | 1,279.28 | 1,261.08 | 1,270.75 | 1,877,165 | |
| 1,263.50 | 1,311.75 | 1,260.17 | 1,283.66 | 2,969,398 | |
| 1,243.39 | 1,259.75 | 1,239.10 | 1,240.34 | 1,960,268 | |
| 1,256.00 | 1,274.56 | 1,251.25 | 1,257.03 | 2,413,950 | |
| 1,235.04 | 1,275.88 | 1,230.66 | 1,251.61 | 3,755,241 |
Dilution timeline
As of
- · 424B2 · Prospectus filed
- · 424B2 · Prospectus filed
- · FWP · Free writing prospectus filed
- · S-3ASR · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue